Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Current Opinion in Pharmacology|December 19, 2006
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmissionAldemar Degroot, George G NomikosNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2004
Fluoxetine disrupts the integration of anxiety and aversive memoriesAldemar Degroot, George G NomikosEuropean Journal of Pharmacology|February 4, 2006
Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying modelAldemar Degroot, George G NomikosThe European Journal of Neuroscience|August 13, 2004
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying testAldemar Degroot, George G NomikosPsychopharmacology|August 3, 2005
Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidineMark R Wade, George G NomikosCurrent Drug Abuse Reviews|July 28, 2009
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing propertiesGeorge Panagis, Styliani Vlachou, George G NomikosThe International Journal of Neuropsychopharmacology|January 6, 2010
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of maniaMaria Mavrikaki, George G Nomikos, George PanagisPsychopharmacology|April 12, 2005
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the ratStyliani Vlachou, George G Nomikos, George PanagisBehavioural Brain Research|May 14, 2003
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulationStyliani Vlachou, George G Nomikos, George PanagisPsychopharmacology|September 6, 2006
Effects of endocannabinoid neurotransmission modulators on brain stimulation rewardStyliani Vlachou, George G Nomikos, George PanagisPageof 7